Aeglea BioTherapeutics Announces Leadership Transition and Corporate Restructuring
/PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as...
Source: prnewswire.com